Skip to main content

Table 4 Exploratory outcomes (presented as rates per patient-year)

From: A pilot study of the functionality and clinician acceptance of a clinical decision support tool to improve primary care of opioid use disorder

Outcome Patient sample Period Control PCPs Intervention PCPs
Waivered
n = 23 No
n = 24
Yes
n = 8
OUD diagnosis Higher risk for OUD Pre 0.008 0.005 0.013
Post 0.062 0.149 0.152
Post/pre 7.87 28.54 11.30
Buprenorphine starts Higher risk for OUD Pre 0 0 0
Post 0 0.029 0.015
Post/pre NA NA NA
Buprenorphine starts Diagnosed with OUD Pre 0.359 0.566 3.666
Post 0.368 0.625 5.127
Post/pre 1.03 1.10 1.40
Naltrexone starts Higher risk for OUD Pre 0 0 0
Post 0.030 0.019 0.041
Post/pre NA NA NA
Naltrexone starts Diagnosed with OUD Pre 0.049 0.049 0.053
Post 0.020 0.074 0.045
Post/pre 0.42 1.52 0.85
Naloxone starts Higher risk for OUD Pre 0.133 0.176 0.256
Post 0.157 0.166 0.122
Post/pre 1.18 0.95 0.48
Naloxone starts Diagnosed with OUD Pre 0.310 0.486 0.481
Post 0.286 0.294 0.295
Post/pre 0.92 0.61 0.61
Referrals to specialty care Higher risk for OUD Pre 0.106 0.101 0.103
Post 0.149 0.130 0.162
Post/pre 1.41 1.29 1.57
Referrals to specialty care Diagnosed with OUD Pre 0.238 0.205 0.283
Post 0.247 0.247 0.281
Post/pre 1.04 1.21 0.99